Live Breaking News & Updates on Exact Sciences Precision Oncology Portfolio

Stay updated with breaking news from Exact sciences precision oncology portfolio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations. ....

Canada , San-antonio , Texas , United-states , Quebec , United-kingdom , Josepha-sparano , Gisela-pedroza , Rick-baehner , Federico-maiardi , Megan-jones , Sciences-corp

EXACT SCIENCES CORP: Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS 2022

New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence Score test, the only genomic test to predict chemotherapy ....

Canada , San-antonio , Texas , United-states , Quebec , United-kingdom , Josepha-sparano , Gisela-pedroza , Rick-baehner , Federico-maiardi , Megan-jones , Sciences-corp

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

/PRNewswire/ Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations. ....

Canada , San-antonio , Texas , United-states , Quebec , United-kingdom , Josepha-sparano , Gisela-pedroza , Rick-baehner , Federico-maiardi , Megan-jones , Sciences-corp